Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Cardiome Pharma Corporation
Cardiome Pharma shares soared 40 percent on over 3 million shares traded Tuesday.
The company has reached a deal with Merck & Co. to settle debt obligations related to vernakalant, an atrial fibrillation treatment.
Going forward ... (see research report)
Subscribe to News Feeds